T 0446/13 of 28.02.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T044613.20170228
- Date of decision
- 28 February 2017
- Case number
- T 0446/13
- Petition for review of
- -
- Application number
- 05744221.2
- IPC class
- A61K 9/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CHEWABLE, SUCKABLE AND SWALLOWABLE TABLET CONTAINING A CALCIUM-CONTAINING COMPOUND AS AN ACTIVE SUBSTANCE
- Applicant name
- Takeda Nycomed AS
- Opponent name
- Bayer Consumer Care AG
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 101(3)European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 56European Patent Convention Art 84
- Keywords
- Amendments - allowable (yes)
Claims - clarity in opposition appeal proceedings
Grounds for opposition - insufficiency of disclosure (no)
Inventive step (yes) - Catchword
- -
- Cited cases
- G 0003/14
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form on the basis of the set of claims filed with letter of 30 August 2013 as second auxiliary request and a description to be adapted.